Complete results of regression analyses of the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

eQTL analysis for proxy SNPs of <i>PRMT6</i>-<i>NTNG1</i> rs12028323. by Dai Nogimura (21445649)

Subjects:

Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Results of RF regression model validation and significance of influencing factors (desert area change and spatiotemporal characteristics of ERI). by Mingyue Sun (4638535)

Significant repeated measurements sEMG outcomes. by María Benito-de-Pedro (22057468)

Subjects:

Significant single measurement sEMG outcomes. by María Benito-de-Pedro (22057468)

Subjects:

Joinpoint regression trends in crude hospitalization and mortality rates of HPV-associated cancers in Mexico (2011–2019). by Juan Carlos Orengo (21546581)

Subjects:

Distribution of HPV-associated and attributable cancer deaths by type and sex, Mexico, 2011-2019. by Juan Carlos Orengo (21546581)

Subjects:

Hospitalizations for HPV-associated and HPV-attributable cancers by type and sex in Mexico (2011-2019): total numbers, averages, and crude rates per 100,000 population. by Juan Carlos Orengo (21546581)

Subjects:

Trends in age-standardized hospitalization rates by HPV-associated cancer type and sex (2011–2019): annual percentage change and average annual percentage change. by Juan Carlos Orengo (21546581)

Subjects:

Mortality for HPV-associated and HPV-attributable cancers by type and sex in Mexico (2011-2019): total numbers, averages, and crude rates per 100,000 population. by Juan Carlos Orengo (21546581)

Subjects:

Joinpoint regression trends in age-standardized hospitalization and mortality rates of HPV-associated cancers in Mexico (2011-2019). by Juan Carlos Orengo (21546581)

Subjects:

Trends in age-standardized mortality rates by HPV-associated cancer type and sex (2011–2019): annual percentage change and average annual percentage change. by Juan Carlos Orengo (21546581)

Subjects:

Distribution of HPV-associated and attributable cancer hospitalizations by type and sex, Mexico, 2011-2019. by Juan Carlos Orengo (21546581)

Subjects:

Age distribution and median age at hospitalization and death by HPV-associated cancer type and sex, Mexico, 2011–2019. by Juan Carlos Orengo (21546581)

Subjects:

Hardware implementation. by Ariel Burman (20329776)

Subjects:

Splenocytes from Tcj2 mRNA LNP—Immunized mice decrease <i>T</i>. <i>cruzi</i> infection <i>in vitro</i>. by Leroy Versteeg (4248760)

Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”

Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”